The overexpression of NOS3 and concomitant NO mediate antiproliferative effects in hepatoblastoma cells through the modulation of the redox state of thioredoxin (Trx) and glutaredoxin (Grx) [24]. The gene discussed is GLRX; the disease is hepatoblastoma.